Emanuele Federico Kauffmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emanuele Federico Kauffmann has a total of 452 co-authors. Here are the top co-authors by number of shared publications:
- Ugo Boggi
Division of General and Transplant Surgery, University of Pisa, Pisa, Italy
31 shared publications - Fabio Vistoli
University of L’Aquila
18 shared publications - Niccolò Napoli
Division of General and Transplant Surgery, University of Pisa, Pisa, Italy
18 shared publications Niccolò Napoli
Division of General and Transplant Surgery, University of Pisa, Pisa, Italy
16 shared publicationsFrancesca Menonna
Univ Pisa, Div Gen & Transplant Surg, Via Paradisa 2, I-56124 Pisa, Italy
11 shared publicationsGabriella Amorese
Division of Anesthesia and Intensive Care, University of Pisa, Pisa, Italy
10 shared publications
Latest Publications
- 28 October 2025
- Published by Springer Nature
- p. 101-107
Robotic Pancreaticoduodenectomy with Vascular Resection and Reconstruction
- 28 October 2025
- Published by Springer Nature
- p. 101-107
Robotic Pancreaticoduodenectomy with Vascular Resection and Reconstruction
- Open Access
- 3 July 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Conversion of Robotic Distal Pancreatectomy
Objective: The aim of this study was to identify risk factors for conversion and assess its consequences on clinical outcomes after robotic distal pancreatectomy (RPD). Summary of Background Data: RDP has gained popularity due to its lower conversion rate (3–8%) when compared to laparoscopic distal pancreatectomy (10–20%). Methods: This retrospective multicenter study included RDPs performed at 16 international centers from May 2007 to March 2024. Perioperative outcomes of patients requiring conversion were compared to fully robotic RDP patients. Risk factors for conversion were identified by multivariable logistic regression analysis. Results: Of 2,452 patients undergoing RDP, 75 (3.1%) required conversion to open surgery. In converted RDPs, operative time was longer (300 (243–376) vs. 180 (120–240) minutes; PPP=0.017), major complications (41% vs. 25%; PPPP51 mm; OR 2.86 (95% CI 1.56–5.08)), BMI (>28 kg/m2; OR 3.03 (1.75–5.30)), previous abdominal surgery (OR 2.48 (1.31–4.51)), patients outside benchmark criteria (OR 2.09 (1.19–3.72)), and age (>62 years; OR 2.21 (1.24–4.05)) were associated with conversion. Conclusion: This international cohort study confirmed a very low conversion rate for RDP. Yet, converted cases experienced substantially impaired postoperative outcomes, highlighting the need for adequate patient selection through validated difficulty scoring systems.
- 3 July 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Open AccessConversion of Robotic Distal Pancreatectomy
Objective: The aim of this study was to identify risk factors for conversion and assess its consequences on clinical outcomes after robotic distal pancreatectomy (RPD). Summary of Background Data: RDP has gained popularity due to its lower conversion rate (3–8%) when compared to laparoscopic distal pancreatectomy (10–20%). Methods: This retrospective multicenter study included RDPs performed at 16 international centers from May 2007 to March 2024. Perioperative outcomes of patients requiring conversion were compared to fully robotic RDP patients. Risk factors for conversion were identified by multivariable logistic regression analysis. Results: Of 2,452 patients undergoing RDP, 75 (3.1%) required conversion to open surgery. In converted RDPs, operative time was longer (300 (243–376) vs. 180 (120–240) minutes; PPP=0.017), major complications (41% vs. 25%; PPPP51 mm; OR 2.86 (95% CI 1.56–5.08)), BMI (>28 kg/m2; OR 3.03 (1.75–5.30)), previous abdominal surgery (OR 2.48 (1.31–4.51)), patients outside benchmark criteria (OR 2.09 (1.19–3.72)), and age (>62 years; OR 2.21 (1.24–4.05)) were associated with conversion. Conclusion: This international cohort study confirmed a very low conversion rate for RDP. Yet, converted cases experienced substantially impaired postoperative outcomes, highlighting the need for adequate patient selection through validated difficulty scoring systems.
- Open Access
- 18 December 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (1) , 108-118
External Validation of the International Study Group for Pancreatic Surgery Complexity Grading System for Minimally Invasive Pancreatoduodenectomy
Objective: To validate the International Study Group for Pancreatic Surgery (ISGPS) complexity grading system for minimally invasive pancreaticoduodenectomy (MIPD). Background: Although concerns about patient safety persist, MIPD is gaining popularity. The ISGPS recently introduced a difficulty grading system to improve patient selection by aligning procedural complexity with surgeon and center expertise. Methods: Data from MIPD cases reported in the IGOMIPS registry (October 2019–February 2024) were analyzed, with severe postoperative complications as the primary outcome. Logistic regression was used to identify risk factors for complications. Results: Of the 771 MIPD cases, 426 (55.3%) were analyzed. A pancreatic duct size ≤3 mm was the only significant risk factor for severe complications (odds ratio = 2.22, P = 0.0001). Most cases (n = 255; 59.9%) were classified as grade C complexity, whereas 22 (5.1%) were classified as grade A. Severe postoperative complications increased with complexity (grade A, 31.8%; grade B, 36.3%; grade C, 48.6%; P = 0.0091). For grade A complexity, the outcomes were consistent across surgeons and centers. Grade B outcomes were similar between grade B and C centers but superior to grade A centers. In grade C cases, outcomes were comparable between grade A and B centers, with improvements at grade C centers. Grade A ISGPS experience correlated strongly with mismatches between planned and performed procedures (grade A, 15.0%; grade B, 3.0%; grade C, 3.1%; P < 0.0001), including total pancreatectomy (grade A, 11.5%; grade B, 1.2%; grade C, 3.1%; P = 0.0005). Conclusions: The ISGPS complexity grading system effectively predicted MIPD outcomes, supporting better patient selection and alignment of complexity with surgical expertise.
- 18 December 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (1) , 108-118
Open AccessExternal Validation of the International Study Group for Pancreatic Surgery Complexity Grading System for Minimally Invasive Pancreatoduodenectomy
Objective: To validate the International Study Group for Pancreatic Surgery (ISGPS) complexity grading system for minimally invasive pancreaticoduodenectomy (MIPD). Background: Although concerns about patient safety persist, MIPD is gaining popularity. The ISGPS recently introduced a difficulty grading system to improve patient selection by aligning procedural complexity with surgeon and center expertise. Methods: Data from MIPD cases reported in the IGOMIPS registry (October 2019–February 2024) were analyzed, with severe postoperative complications as the primary outcome. Logistic regression was used to identify risk factors for complications. Results: Of the 771 MIPD cases, 426 (55.3%) were analyzed. A pancreatic duct size ≤3 mm was the only significant risk factor for severe complications (odds ratio = 2.22, P = 0.0001). Most cases (n = 255; 59.9%) were classified as grade C complexity, whereas 22 (5.1%) were classified as grade A. Severe postoperative complications increased with complexity (grade A, 31.8%; grade B, 36.3%; grade C, 48.6%; P = 0.0091). For grade A complexity, the outcomes were consistent across surgeons and centers. Grade B outcomes were similar between grade B and C centers but superior to grade A centers. In grade C cases, outcomes were comparable between grade A and B centers, with improvements at grade C centers. Grade A ISGPS experience correlated strongly with mismatches between planned and performed procedures (grade A, 15.0%; grade B, 3.0%; grade C, 3.1%; P < 0.0001), including total pancreatectomy (grade A, 11.5%; grade B, 1.2%; grade C, 3.1%; P = 0.0005). Conclusions: The ISGPS complexity grading system effectively predicted MIPD outcomes, supporting better patient selection and alignment of complexity with surgical expertise.
- Open Access
- 19 November 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (1) , e22-e30
Competency, Proficiency, and Mastery
Objective: The aim of this study was to evaluate the different phases of the learning curve for robotic distal pancreatectomy (RDP) in international expert centers. Background: RDP is an emerging minimally invasive approach; however, only limited, mostly single-center data are available on its safe implementation, including the learning curve. Methods: Consecutive patients undergoing elective RDP from 16 expert centers across 3 continents were included to assess the learning curve. Based on the first 100 RDPs at each center, 3 cutoffs were used to define the learning curve: operative time for competency, major complications (Clavien-Dindo grade ≥III) for proficiency, and textbook outcome for mastery. Clinical outcomes before and after the cutoffs were compared. Results: The learning curve analysis was conducted on 1109 of 2403 RDPs. Competency, proficiency, and mastery, respectively, were reached after 46, 63, and 73 RDP procedures. After competency, operative time decreased from 245 to 235 minutes ( P = 0.002). Attaining proficiency was reflected by a reduction in the rate of major complications from 20% to 15% ( P = 0.012), and mastery was associated with a higher proportion of patients with textbook outcomes (71% vs 63%; P = 0.028). The postoperative pancreatic fistula rate remained stable along the learning curve, ranging between 18.5% and 21.5%. Previous laparoscopic experience accelerated the learning process by virtue of reduced operative time and an earlier decrease in major complications. Conclusions: Competency, proficiency, and mastery for RDP were reached after 46, 63, and 73 procedures, respectively, at international expert centers. The findings highlight that the learning curves for intraoperative parameters are completed earlier; however, extensive experience is needed to master RDP.
- 19 November 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (1) , e22-e30
Open AccessCompetency, Proficiency, and Mastery
Objective: The aim of this study was to evaluate the different phases of the learning curve for robotic distal pancreatectomy (RDP) in international expert centers. Background: RDP is an emerging minimally invasive approach; however, only limited, mostly single-center data are available on its safe implementation, including the learning curve. Methods: Consecutive patients undergoing elective RDP from 16 expert centers across 3 continents were included to assess the learning curve. Based on the first 100 RDPs at each center, 3 cutoffs were used to define the learning curve: operative time for competency, major complications (Clavien-Dindo grade ≥III) for proficiency, and textbook outcome for mastery. Clinical outcomes before and after the cutoffs were compared. Results: The learning curve analysis was conducted on 1109 of 2403 RDPs. Competency, proficiency, and mastery, respectively, were reached after 46, 63, and 73 RDP procedures. After competency, operative time decreased from 245 to 235 minutes ( P = 0.002). Attaining proficiency was reflected by a reduction in the rate of major complications from 20% to 15% ( P = 0.012), and mastery was associated with a higher proportion of patients with textbook outcomes (71% vs 63%; P = 0.028). The postoperative pancreatic fistula rate remained stable along the learning curve, ranging between 18.5% and 21.5%. Previous laparoscopic experience accelerated the learning process by virtue of reduced operative time and an earlier decrease in major complications. Conclusions: Competency, proficiency, and mastery for RDP were reached after 46, 63, and 73 procedures, respectively, at international expert centers. The findings highlight that the learning curves for intraoperative parameters are completed earlier; however, extensive experience is needed to master RDP.
- 8 October 2024
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (2) , 459-466
Current management of hepatobiliary malignancies between centers with or without a liver transplant program: A multi-society national survey
- 8 October 2024
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (2) , 459-466
Current management of hepatobiliary malignancies between centers with or without a liver transplant program: A multi-society national survey
- Open Access
- 6 April 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 40, 100900
Disentangling seemingly contradictory results of the first two randomised controlled trials comparing open and robotic pancreatoduodenectomy
- 6 April 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 40, 100900
Open AccessDisentangling seemingly contradictory results of the first two randomised controlled trials comparing open and robotic pancreatoduodenectomy
- Open Access
What Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis?
Minimally invasive liver surgery (MILS) has been slowly introduced in the past two decades and today represents a major weapon in the fight against HCC, for several reasons. This narrative review conveys the major emerging concepts in the field. The rise in metabolic-associated steatotic liver disease (MASLD)-related HCC means that patients with significant cardiovascular risk will benefit more profoundly from MILS. The advent of efficacious therapy is leading to conversion from non-resectable to resectable cases, and therefore more patients will be able to undergo MILS. In fact, resection outcomes with MILS are superior compared to open surgery both in the short and long term. Furthermore, indications to surgery may be further expanded by its use in Child B7 patients and by the use of laparoscopic ablation, a curative technique, instead of trans-arterial approaches in cases not amenable to radiofrequency. Therefore, in a promising new approach, multi-parametric treatment hierarchy, MILS is hierarchically superior to open surgery and comes second only to liver transplantation.
Open AccessWhat Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis?
Minimally invasive liver surgery (MILS) has been slowly introduced in the past two decades and today represents a major weapon in the fight against HCC, for several reasons. This narrative review conveys the major emerging concepts in the field. The rise in metabolic-associated steatotic liver disease (MASLD)-related HCC means that patients with significant cardiovascular risk will benefit more profoundly from MILS. The advent of efficacious therapy is leading to conversion from non-resectable to resectable cases, and therefore more patients will be able to undergo MILS. In fact, resection outcomes with MILS are superior compared to open surgery both in the short and long term. Furthermore, indications to surgery may be further expanded by its use in Child B7 patients and by the use of laparoscopic ablation, a curative technique, instead of trans-arterial approaches in cases not amenable to radiofrequency. Therefore, in a promising new approach, multi-parametric treatment hierarchy, MILS is hierarchically superior to open surgery and comes second only to liver transplantation.
- Open Access
- 11 December 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (10) , 6111-6125
Postoperative results, learning curve, and outcomes of pancreatectomy with arterial resection: a single-center retrospective cohort study on 236 procedures
Background: Newer chemotherapy regimens are reviving the role of pancreatectomy with arterial resection (PAR) in locally advanced pancreatic cancer. However, concerns about the early outcomes and learning curve of PAR remain. This study aimed to define the postoperative results and learning curve of PAR and provide preliminary data on oncologic outcomes. Materials and methods: A single center’s experiences (1993–2023) were retrospectively analyzed to define the postoperative outcomes and learning curve of PAR. Oncologic results were also reported. Results: During the study period 236 patients underwent PAR. Eighty PAR (33.9%) were performed until 2012, and 156 were performed thereafter (66.1%). Pancreatic cancer was diagnosed histologically in 183 patients (77.5%). Induction therapy was delivered to 18 of these patients (31.0%) in the early experience and to 101 patients (80.8%) in the last decade (PP=0.0055]. Comparison between the PAR-SMA and PAR-CT/HA groups showed no differences in severe postoperative complications (25.3 vs. 20.6%), 90-day mortality (12.6 vs. 7.8%), and median overall survival. Vascular invasion was confirmed in 123 patients (67.2%). The median number (interquartile range) of examined lymph nodes was 60.5 (41.3–83) and rate of R0 resection was 66.1% (121/183). Median overall survival for PAR was 20.9 (12.5–42.8) months, for PAR-SMA was 20.2 (14.4–44) months, and for PAR-CT/HA was 20.2 (11.4–42.7). Long-term prognosis improved by study decade [1993–2002: 12.0 (5.4–25.9) months, 2003–2012: 15.1 (9.8–23.4) months, and 2013–present: 26.2 (14.3–51.5) months; P<0.0001]. Conclusions: In recent times, PAR is associated with improved outcomes despite a steep learning curve. Pancreatic surgeons should be prepared to face the technical challenge posed by PAR.
- 11 December 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (10) , 6111-6125
Open AccessPostoperative results, learning curve, and outcomes of pancreatectomy with arterial resection: a single-center retrospective cohort study on 236 procedures
Background: Newer chemotherapy regimens are reviving the role of pancreatectomy with arterial resection (PAR) in locally advanced pancreatic cancer. However, concerns about the early outcomes and learning curve of PAR remain. This study aimed to define the postoperative results and learning curve of PAR and provide preliminary data on oncologic outcomes. Materials and methods: A single center’s experiences (1993–2023) were retrospectively analyzed to define the postoperative outcomes and learning curve of PAR. Oncologic results were also reported. Results: During the study period 236 patients underwent PAR. Eighty PAR (33.9%) were performed until 2012, and 156 were performed thereafter (66.1%). Pancreatic cancer was diagnosed histologically in 183 patients (77.5%). Induction therapy was delivered to 18 of these patients (31.0%) in the early experience and to 101 patients (80.8%) in the last decade (PP=0.0055]. Comparison between the PAR-SMA and PAR-CT/HA groups showed no differences in severe postoperative complications (25.3 vs. 20.6%), 90-day mortality (12.6 vs. 7.8%), and median overall survival. Vascular invasion was confirmed in 123 patients (67.2%). The median number (interquartile range) of examined lymph nodes was 60.5 (41.3–83) and rate of R0 resection was 66.1% (121/183). Median overall survival for PAR was 20.9 (12.5–42.8) months, for PAR-SMA was 20.2 (14.4–44) months, and for PAR-CT/HA was 20.2 (11.4–42.7). Long-term prognosis improved by study decade [1993–2002: 12.0 (5.4–25.9) months, 2003–2012: 15.1 (9.8–23.4) months, and 2013–present: 26.2 (14.3–51.5) months; P<0.0001]. Conclusions: In recent times, PAR is associated with improved outcomes despite a steep learning curve. Pancreatic surgeons should be prepared to face the technical challenge posed by PAR.